These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2419348)

  • 1. Characterization of plasminogen activator from two human renal carcinoma cell lines.
    Nelson NF; Cieplak W; Dacus SC; Prager MD
    J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells.
    Moscatelli D
    J Cell Biochem; 1986; 30(1):19-29. PubMed ID: 3082899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of plasminogen activator produced by an established cell line from human ovary.
    Matsuo C; Fukao H; Matsuo O
    J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R; Andersson LC; Tapiovaara H; Sistonen L; Vaheri A; Stephens R
    J Cell Physiol; 1989 Jul; 140(1):119-30. PubMed ID: 2500450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human hepatoma cell line plasminogen activator.
    Levin EG; Fair DS; Loskutoff DJ
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.
    Wagner OF; de Vries C; Hohmann C; Veerman H; Pannekoek H
    J Clin Invest; 1989 Aug; 84(2):647-55. PubMed ID: 2503541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.
    Sitrin RG; Gyetko MR; Kole KL; McKeever P; Varani J
    Cancer Res; 1990 Aug; 50(16):4957-61. PubMed ID: 2379161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of stable complexes between urokinase and a human urinary component.
    Cieplak W; Hart DA
    Thromb Haemost; 1985 Feb; 53(1):36-41. PubMed ID: 4039474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines.
    Festoff BW; Rao JS; Maben C; Hantaï D
    J Cell Physiol; 1990 Aug; 144(2):262-71. PubMed ID: 2199466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
    Laug WE
    Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a functionally active tPA-like plasminogen activator in human platelets.
    Wang DL; Pan YT; Wang JJ; Cheng CH; Liu CY
    Thromb Haemost; 1994 Apr; 71(4):493-8. PubMed ID: 8052969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid modulates extracellular urokinase-type plasminogen activator activity in DU-145 human prostatic carcinoma cells.
    Waghray A; Webber MM
    Clin Cancer Res; 1995 Jul; 1(7):747-53. PubMed ID: 9816041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells.
    Band V; Karlan BY; Zurawski VR; Littlefield BA
    J Cell Physiol; 1989 Jan; 138(1):106-14. PubMed ID: 2492025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human articular cartilage contains an inhibitor of plasminogen activator.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Rheumatol; 1988 Jul; 15(7):1138-43. PubMed ID: 3139880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture.
    Orenstein NS; Buczynski A; Dvorak HF
    Cancer Res; 1983 Apr; 43(4):1783-9. PubMed ID: 6682008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and cellular localization of plasminogen activators from human glomeruli.
    Angles-Cano E; Rondeau E; Delarue F; Hagege J; Sultan Y; Sraer JD
    Thromb Haemost; 1985 Oct; 54(3):688-92. PubMed ID: 3937266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contact-system dependent plasminogen activator from human plasma: identification and characterization.
    Binnema DJ; Dooijewaard G; van Iersel JJ; Turion PN; Kluft C
    Thromb Haemost; 1990 Nov; 64(3):390-7. PubMed ID: 2128968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.